Elan appoints Hans Peter Hasler as Chief Operating Officer
24 September 2012 | By Elan Corporation
Mr. Hasler is currently a non-executive director of the Company and he will retire from the board of directors of the Company...
List view / Grid view
24 September 2012 | By Elan Corporation
Mr. Hasler is currently a non-executive director of the Company and he will retire from the board of directors of the Company...
21 September 2012 | By Pittcon
The Registration Committee is pleased to announce that conferee registration is now open for Pittcon 2013, which will be held March 17-21, 2013...
21 September 2012 | By Daiichi Sankyo
Data from the PRASFIT-ACS study...
20 September 2012 | By Sanofi
Sanofi and TB Alliance have announced a new research collaboration agreement...
20 September 2012 | By Boehringer Ingelheim
Submission of a MAA to the EMA for approval of afatinib*...
20 September 2012 | By Amgen
A new indication for Prolia® approved...
19 September 2012 | By Citigate Dewe Rogerson
Wellington Partners announces the successful first closing of its new Wellington Partners IV Life Science Fund...
19 September 2012 | By Bristol-Myers Squibb
New non-profit organization to speed pharmaceutical R&D...
18 September 2012 | By Azbil BioVigilant
Azbil BioVigilant has entered into a distribution agreement with Archilex...
18 September 2012 | By kdm communications limited
Tecan understands that flexibility is crucial to making laboratory automation work for you...
18 September 2012 | By Merck
“We are disappointed that we have not been able to move forward with the filing..."
18 September 2012 | By B&W Tek Inc
B&W Tek, Inc. is proud to announce the expansion of their Exemplar® smart spectrometer platform.
17 September 2012 | By Gerresheimer Group
The healthcare sector needs innovative packaging solutions. Gerresheimer’s comprehensive portfolio of products extends...
17 September 2012 | By GlaxoSmithKline
GSK has submitted a regulatory application in the European Union seeking approval of an additional indication for Synflorix™...
17 September 2012 | By Pfizer
14 abstracts for tofacitinib...